Baiao Harbor: The US Food and Drug Administration issued a partial clinical moratorium on September 4, 2026 to stop the enrollment of new BHV-7000 subjects.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.